Telix to acquire ImaginAb’s therapeutic assets for up to $230m
The agreement includes ImaginAb's therapeutic pipeline, biologics platform, and protein engineering research facility to enhance Telix Pharmaceuticals’ innovation capabilities
Light Horse established with $62m financing, partners with Novartis
Health Canada approves Vyloy for first-line gastric cancer treatment
Boehringer Ingelheim broadens oncology portfolio with license for Synaffix’s ADC technology
Nipocalimab granted US FDA Priority Review for the treatment of generalized myasthenia gravis
Vividion acquires Tavros to expand drug discovery platform
Analysis
View More
Risks
View MoreSocietal polarisation and its impact on the pharmaceutical industry
Societal polarisation presents significant challenges for the pharmaceutical industry, affecting regulatory landscapes, public trust, innovation, and market dynamics
Effects of interstate armed conflicts on the pharmaceutical industry
Unveiling the impact of misinformation and disinformation in the pharmaceutical industry
The ripple effects of inflation on the pharmaceutical industry
Extreme weather events: The implications for the pharmaceutical industry